J&J says new tests find no asbestos in same baby powder bottle that sparked recall
(Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says…
Man wins lottery prize on way for cancer treatment
A North Carolina man won a $200,000 lottery prize while on the way to his last round of chemotherapy. WTVD-TV reports that Ronnie Foster bought the winning scratch-off ticket before…
Direct-to-consumer genetic test results may be unreliable
(Reuters Health) – Genetic tests sold online or in stores may produce false results, warn genetics experts in the UK. When one of these tests indicates a “health risk,” it…
Current and ex smokers may lower lung cancer risk with exercise
(Reuters Health) – Men who are current or former smokers may be less likely to develop or die from lung cancer when they’re more physically fit, a recent study suggests.…
Sanofi pulls Zantac from U.S. and Canada after carcinogen found
NEW YORK (Reuters) – Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable…
Lilly’s pancreatic cancer treatment fails late-stage study
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg,…
Bristol-Myers immunotherapy combo outperforms chemo in lung cancer survival: study
(Reuters) – About 40% of patients who received a combination of Bristol-Myers Squibb Co’s immuno-oncology drugs Opdivo and Yervoy as an initial treatment for advanced non-small cell lung cancer (NSCLC)…
Targeted Amgen drug has low response rate in colon cancer in study
(Reuters) – An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12 patients with advanced colorectal cancer who were given the highest…
Results of GSK and AstraZeneca trials may widen ovarian cancer drug use
BARCELONA (Reuters) – GlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a wider group of ovarian cancer patients, possibly helping GSK catch…
E-sniffer predicts non-responders to lung cancer immunotherapy
An electronic “nose” that detects chemicals in the breath of lung cancer patients may help distinguish between those who will and will not respond to immunotherapy, a new study suggests.…